These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1680340)

  • 1. Frequent activation of the Ki-ras oncogene at codon 12 in N-methyl-N-nitrosourea-induced rat prostate adenocarcinomas and neurogenic sarcomas.
    Sukumar S; Armstrong B; Bruyntjes JP; Leav I; Bosland MC
    Mol Carcinog; 1991; 4(5):362-8. PubMed ID: 1680340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of ras and p53 gene mutations in carcinomas in the forestomach and intestine and soft tissue sarcomas induced by N-methyl-N-nitrosourea in the rat.
    Matsumoto K; Iwase T; Hirono I; Nishida Y; Iwahori Y; Hori T; Asamoto M; Takasuka N; Kim DJ; Ushijima T; Nagao M; Tsuda H
    Jpn J Cancer Res; 1997 Feb; 88(2):129-36. PubMed ID: 9119740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis.
    Asamoto M; Ochiya T; Toriyama-Baba H; Ota T; Sekiya T; Terada M; Tsuda H
    Carcinogenesis; 2000 Feb; 21(2):243-9. PubMed ID: 10657964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous vs. intraprostatic administration of N-methyl-N-nitrosourea to induce prostate cancer in rats.
    Schleicher RL; Fallon MT; Austin GE; Zheng M; Zhang M; Dillehay DL; Collins DC
    Prostate; 1996 Jan; 28(1):32-43. PubMed ID: 8545279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
    Hal DG; Stoica G
    Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of O6-methylguanine-DNA methyltransferase mRNA levels in Ha-ras mutated and non-mutated rat mammary tumors induced by N-methyl-N-nitrosourea.
    Inui H; Watatani M; Yasutomi M; Nishisho I
    Carcinogenesis; 1994 Mar; 15(3):459-63. PubMed ID: 8118929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of Ki-ras mutations in exocrine pancreatic tumors from male rats chronically exposed to gabapentin.
    Fowler ML; Sigler RE; de la Iglesia FA; Reddy JK; Lalwani ND
    Mutat Res; 1995 Mar; 327(1-2):151-60. PubMed ID: 7870083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ras oncogene activation in mammary carcinomas induced by N-methyl-N-nitrosourea in Copenhagen rats.
    Lu SJ; Archer MC
    Mol Carcinog; 1992; 6(4):260-5. PubMed ID: 1485917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
    Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
    Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki-ras mutations in spontaneous and chemically induced renal tumors of the rat.
    Ohgaki H; Kleihues P; Hard GC
    Mol Carcinog; 1991; 4(6):455-9. PubMed ID: 1793484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine.
    Wang Y; You M; Reynolds SH; Stoner GD; Anderson MW
    Cancer Res; 1990 Mar; 50(5):1591-5. PubMed ID: 2406014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ha-ras oncogene activation in mammary glands of N-methyl-N-nitrosourea-treated rats genetically resistant to mammary adenocarcinogenesis.
    Lu SJ; Archer MC
    Proc Natl Acad Sci U S A; 1992 Feb; 89(3):1001-5. PubMed ID: 1736280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple pathways of prostate carcinogenesis analyzed by using cultured cells isolated from rats treated with N-methyl-N-nitrosourea and testosterone.
    Condon MS; Kaplan LA; Crivello JF; Horton L; Bosland MC
    Mol Carcinog; 1999 Jul; 25(3):179-86. PubMed ID: 10411144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational status of codons 12 and 13 of the N- and K-ras genes in tissue and cell lines derived from primary and metastatic prostate carcinomas.
    Pergolizzi RG; Kreis W; Rottach C; Susin M; Broome JD
    Cancer Invest; 1993; 11(1):25-32. PubMed ID: 7678540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of Ki-ras mutations and DNA alkylation in colorectal tissue from individuals living in Manchester.
    Jackson PE; Hall CN; Badawi AF; O'Connor PJ; Cooper DP; Povey AC
    Mol Carcinog; 1996 May; 16(1):12-9. PubMed ID: 8634090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent mutations of Ki-ras but no mutations of Ha-ras and p53 in lung lesions induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
    Kitada H; Tsutsumi M; Tsujiuchi T; Takahama M; Fukuda T; Narita N; Konsihi Y
    Mol Carcinog; 1996 Apr; 15(4):276-83. PubMed ID: 8634086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
    Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
    J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers.
    Nagata Y; Abe M; Kobayashi K; Yoshida K; Ishibashi T; Naoe T; Nakayama E; Shiku H
    Cancer Res; 1990 Feb; 50(3):480-2. PubMed ID: 2404571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.